Furthermore, the conjugation of the anti-EGFR aptamer with the anti-CTLA-4mAb allowed also for the efficient killing of cancer cells mediated by effector and NK lymphocytes in co-cultures of tumor cells with both hPBMCs or NK cells, thus strongly increasing the cytotoxicity of the two partners in the chimeric construct. This evidence concerns the gene EGFR and neoplasm.